CVS Health Corporation (CVS)
CVS ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by CVS Health Corporation
NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of CVS Health Corporation ("CVS Health Corporation") (NYSE:CVS) concerning possible violations of federal securities laws. The U.S. Department of Justice filed a complaint on May 1, 2025, against insurance broker organizations, including CVS, alleging that "insurers paid hundreds of millions of dollars in illegal kickbacks to the defendant brokers in exchange for enrollments in the insurers' Medicare Advantage plans.
CVS Health Corporation Being Investigated on Behalf of CVS Health Corporation Investors. Contact Levi & Korsinsky For Details
NEW YORK, NY / ACCESS Newswire / May 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of CVS Health Corporation ("CVS Health Corporation") (NYSE:CVS) concerning possible violations of federal securities laws. The U.S. Department of Justice filed a complaint on May 1, 2025, against insurance broker organizations, including CVS, alleging that "insurers paid hundreds of millions of dollars in illegal kickbacks to the defendant brokers in exchange for enrollments in the insurers' Medicare Advantage plans.
CVS Health celebrates reopening of Hendersonville store destroyed by Hurricane Helene
The South Main Street CVS Pharmacy is again providing health, wellness and pharmacy services to customers and patients WOONSOCKET, R.I. , May 12, 2025 /PRNewswire/ -- Today, leaders from CVS Health® (NYSE: CVS) were joined by state and local representatives to celebrate the reopening of one of its Hendersonville CVS Pharmacy stores.
CVS Health: Big 2025 Momentum, Strong Growth Ahead, Shares Underpriced
CVS Health has shown impressive year-to-date performance, driven by strong Q1 results and strategic shifts in its business model. I reiterate a buy rating on CVS due to its low valuation, mixed technicals, and promising earnings growth prospects. Key catalysts include improved performance in Healthcare Benefits, higher star ratings in Medicare Advantage, and strategic exits from less profitable areas.
CVS Health: Firing On All Cylinders, Thanks To The Promising Reversal
CVS' turnaround may be here, given the seemingly stabilizing medical cost trends as similarly reported by its peers, with it triggering the moderating Medical Benefit Ratio. This is despite the stable enrollments and the higher utilization, thanks to its improved Medicare Advantage star ratings and the growth in its commercial-fee businesses. We are likely to see CVS' Health Care Benefits segment report sequential improvements after the exit from the Affordable Care Act [ACA] plans from 2026 onwards as well.
ATTENTION CVS SHAREHOLDERS: Investors Who Lost Money on CVS Health Corporation Are Urged to Contact Levi & Korsinsky About an Ongoing Investigation
NEW YORK, NY / ACCESS Newswire / May 8, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of CVS Health Corporation ("CVS Health Corporation") (NYSE:CVS) concerning possible violations of federal securities laws. The U.S. Department of Justice filed a complaint on May 1, 2025, against insurance broker organizations, including CVS, alleging that "insurers paid hundreds of millions of dollars in illegal kickbacks to the defendant brokers in exchange for enrollments in the insurers' Medicare Advantage plans.
Kirby McInerney LLP Announces Investigation of Claims Against CVS Health Corporation (CVS) on Behalf of Investors
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against CVS Health Corporation (“CVS” or the “Company”) (NYSE:CVS). The investigation concerns whether CVS and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
Glenview Capital Issues Statement on CVS Health
NEW YORK , May 6, 2025 /PRNewswire/ -- One year ago, we established a concentrated position in shares of CVS Health (NYSE: CVS). Since our purchases in May 2024, CVS shares have generated a total return of 25% reflecting initial progress in the long-term cultural and operational turnaround underway at the Company.
What Makes CVS Health (CVS) a New Buy Stock
CVS Health (CVS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Wall Street Analysts Think CVS Health (CVS) Is a Good Investment: Is It?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Is Most-Watched Stock CVS Health Corporation (CVS) Worth Betting on Now?
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
CVS Health (CVS) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
